drug
trientine tetrahydrochloride
Marketedupdated 3mo agoby Orphalan SA
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 28, 2029
~2.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- May 3, 2039compositionUS 10988436
- May 3, 2039method-of-use (U-3370)US 11072577
- May 3, 2039compositionUS 12358861
- May 3, 2039compositionUS 12358862
FDA exclusivities (1)
- Apr 28, 2029ODE-401Orphan Drug (7y)2.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that